Diagnoses and mortality in a population without acute myocardial infarction, but with elevated high-sensitive

R S Hansen1, J Revsholm1, D P Henriksen1

  • 1Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Denmark.

Acute Medicine
|March 22, 2021
PubMed

Insights

Elevated high-sensitive troponin I (hs-TnI) without acute myocardial infarction (AMI) is linked to serious conditions like pneumonia and heart failure. Careful evaluation is crucial due to high mortality rates in these patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Diagnostics

Background:

  • Elevated cardiac troponins are a key indicator of myocardial injury.
  • Acute myocardial infarction (AMI) is the primary diagnosis considered.
  • Differential diagnoses for elevated troponins without AMI require further investigation.

Purpose of the Study:

  • To identify differential diagnoses in patients with elevated high-sensitive troponin I (hs-TnI) but without acute myocardial infarction (AMI).
  • To determine the mortality rates associated with elevated hs-TnI in the absence of AMI.

Main Methods:

  • Retrospective, register-based study.
  • Utilized a representative Danish population sample.
  • Included individuals aged 18+ with hs-TnI ≥ 25 ng/L, excluding AMI cases.

Main Results:

  • 3067 individuals without AMI but with elevated hs-TnI were analyzed.
  • Most frequent discharge diagnoses included pneumonia (12.8%), aortic valve disorder (11.3%), medical observation (10.9%), and heart failure (8.9%).
  • 30-day and one-year mortality rates were 15.8% and 32.0%, respectively.

Conclusions:

  • Several alternative diagnoses should be considered in patients presenting with elevated hs-TnI without AMI.
  • The high mortality observed underscores the critical need for thorough evaluation of these individuals, even when AMI is ruled out.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
78
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
509
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
255
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
119
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
92
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
182